Contact this trialFirst, we need to learn more about you.
Behavioral Intervention
Metformin + Exercise for Metabolic Syndrome
Recruiting0 awardsPhase 2 & 3
New Brunswick, New Jersey
This trial is testing whether metformin, a common anti-diabetes medication, has any effect on the vascular function of obese people with Metabolic syndrome (MetS) when combined with exercise. The study will last 16 weeks and participants will be randomly assigned to one of four groups: 1) low-intensity exercise + placebo; 2) low-intensity exercise + metformin; 3) high-intensity exercise + placebo; or 4) high-intensity exercise + metformin.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.